Invesco Biotechnology & Genome ETF Rating $96.27 -1.40 (-1.43%) Closing price 09/23/2026 04:10 PM EasternExtended Trading$96.20 -0.07 (-0.07%) As of 04:01 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsShort Interest Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.63Holdings in PBE have an aggregate rating of Moderate Buy based on 465 analyst ratings issued in the past year covering 25 companies (87.8% of the portfolio).PBE Aggregate Price Target$96.27High Prediction$96.27Average Prediction$96.27Low Prediction$96.27Holdings in PBE have an aggregate price target of $96.27 and a range of $96.27 to $96.27 covering 25 companies (87.8% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings5.62%ILMNIllumina$255.38+3.2%Hold$199.13 -22.0%182.1984 of 5 stars5.61%NTRANatera$390.790.0%Moderate Buy$330.83 -15.3%231.6001 of 5 starsTrending News5.23%GILDGilead Sciences$151.37-0.9%Moderate Buy$158.78 4.9%293.4876 of 5 starsTrending NewsAnalyst Revision5.12%BIIBBiogen$227.53+1.0%Moderate Buy$230.14 1.1%322.5365 of 5 stars4.89%RPRXRoyalty Pharma$57.65-1.5%Buy$61.29 6.3%83.8919 of 5 stars4.88%REGNRegeneron Pharmaceuticals$801.82-0.3%Moderate Buy$802.18 0.0%243.7165 of 5 starsAnalyst Forecast4.82%VRTXVertex Pharmaceuticals$516.34+0.3%Moderate Buy$573.83 11.1%233.7852 of 5 starsTrending NewsAnalyst Forecast4.43%AMGNAmgen$406.09-1.0%Hold$383.46 -5.6%303.6037 of 5 starsTrending NewsAnalyst ForecastAnalyst Revision3.07%SRPTSarepta Therapeutics$18.95-8.9%Hold$24.07 27.0%193.6274 of 5 stars2.98%NVAXNovavax$10.55-2.6%Hold$14.00 32.7%92.3518 of 5 stars2.90%EXELExelixis$56.73-2.4%Hold$50.29 -11.4%202.4118 of 5 stars2.87%TGTXTG Therapeutics$56.00-3.6%Hold$63.00 12.5%93.5368 of 5 starsAnalyst Upgrade2.86%QGENQiagen$43.76+0.2%Hold$43.51 -0.6%143.638 of 5 stars2.82%HALOHalozyme Therapeutics$112.44-2.3%Moderate Buy$91.20 -18.9%133.1015 of 5 stars2.80%MRNAModerna$182.11-0.2%Hold$76.72 -57.9%241.9907 of 5 starsTrending NewsAnalyst Forecast2.78%NBIXNeurocrine Biosciences$139.49-1.9%Moderate Buy$201.09 44.2%244.7525 of 5 stars2.77%INCYIncyte$124.64-1.8%Moderate Buy$124.05 -0.5%253.1461 of 5 starsAnalyst Forecast2.77%BMRNBioMarin Pharmaceutical$62.21-1.8%Moderate Buy$89.17 43.3%234.3862 of 5 stars2.76%RGENRepligen$184.53-1.2%Buy$168.57 -8.6%182.3538 of 5 stars2.70%UTHRUnited Therapeutics$489.42-1.6%Moderate Buy$621.00 26.9%144.4329 of 5 starsAnalyst ForecastInsider Trade2.68%PTGXProtagonist Therapeutics$138.70-4.4%Moderate Buy$147.13 6.1%182.109 of 5 starsPositive News2.65%ANABAnaptysBio$50.77-5.8%Moderate Buy$79.15 55.9%163.4509 of 5 starsTrending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.60%PTCTPTC Therapeutics$62.34-5.5%Moderate Buy$99.08 58.9%153.5922 of 5 starsAnalyst Forecast2.60%VCELVericel$38.79-3.6%Moderate Buy$58.40 50.6%63.8403 of 5 starsPositive News2.59%VCYTVeracyte$43.82+1.1%Moderate Buy$55.78 27.3%114.3335 of 5 starsInsider Trade This page (NYSEARCA:PBE) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredCongress Passes Landmark Digital Asset Law Wall Street Is WatchingThe House passed the Digital Asset Market Clarity Act 294 to 134, creating the most comprehensive financial te...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBE Stock Alerts